Seyfettin Ciftci1, Hasan Yilmaz2, Esra Ciftci3, Emrah Simsek2, Murat Ustuner2, Ufuk Yavuz2, Bahar Muezzinoglu4, Ozdal Dillioglugil2. 1. Department of Urology, Sivas Numune State Hospital, Sivas, Turkey. 2. Department of Urology, University of Kocaeli Medical Faculty, Kocaeli, Turkey. 3. Department of Nuclear Medicine, Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey. 4. Department of Pathology, University of Kocaeli Medical Faculty, Kocaeli, Turkey.
Abstract
BACKGROUND: We aimed to evaluate the relationship between perineural invasion (PNI) and bone metastasis in prostate cancer (PCa). METHODS: We retrospectively reviewed the data of 633 PCas who had whole-body bone scan (WBBS) between 2008 and 2014. We recorded the age, clinical T-stage, total PSA (tPSA) prior to biopsy, Gleason sum (GS), and PNI in transrectal ultrasound guided biopsy (TRUS-Bx) and digital rectal examination findings. Bone metastases were assessed with WBBS and magnetic resonance image if WBBS was suspicious. We divided the patients into two groups according to NCCN criteria: (Group 1) bone scan not indicated, (Group 2) bone scan indicated. RESULTS: There were 262 patients in Group 1 and 371 in 2. There is not significant relationship between PNI and bone metastasis in Group 1. However, there is very limited number of metastatic patients (n = 12) in this group. There is a strong relationship between PNI and bone metastasis in Group 2 (P = 0.001). Sensitivity, specificity and positive predictive value of PNI for bone metastasis were 72.4%, 81.7%, and 77.7%, respectively. In this group, tPSA, GS, positive DRE, and PNI were significant covariates for prediction of bone metastasis in univariate and multivariate analysis (except age). The most powerful predictor was PNI, and it increased the risk of bone metastasis 11-fold. CONCLUSIONS: PNI in the TRUS-Bx specimens is the most powerful predictive histopathological feature for bone metastasis, by increasing the risk of bone metastasis 11-fold in NCCN bone scan indicated patients (Group 2).
BACKGROUND: We aimed to evaluate the relationship between perineural invasion (PNI) and bone metastasis in prostate cancer (PCa). METHODS: We retrospectively reviewed the data of 633 PCas who had whole-body bone scan (WBBS) between 2008 and 2014. We recorded the age, clinical T-stage, total PSA (tPSA) prior to biopsy, Gleason sum (GS), and PNI in transrectal ultrasound guided biopsy (TRUS-Bx) and digital rectal examination findings. Bone metastases were assessed with WBBS and magnetic resonance image if WBBS was suspicious. We divided the patients into two groups according to NCCN criteria: (Group 1) bone scan not indicated, (Group 2) bone scan indicated. RESULTS: There were 262 patients in Group 1 and 371 in 2. There is not significant relationship between PNI and bone metastasis in Group 1. However, there is very limited number of metastatic patients (n = 12) in this group. There is a strong relationship between PNI and bone metastasis in Group 2 (P = 0.001). Sensitivity, specificity and positive predictive value of PNI for bone metastasis were 72.4%, 81.7%, and 77.7%, respectively. In this group, tPSA, GS, positive DRE, and PNI were significant covariates for prediction of bone metastasis in univariate and multivariate analysis (except age). The most powerful predictor was PNI, and it increased the risk of bone metastasis 11-fold. CONCLUSIONS: PNI in the TRUS-Bx specimens is the most powerful predictive histopathological feature for bone metastasis, by increasing the risk of bone metastasis 11-fold in NCCN bone scan indicated patients (Group 2).
Authors: Lars Egevad; Brett Delahunt; Hemamali Samaratunga; Toyonori Tsuzuki; Henrik Olsson; Peter Ström; Cecilia Lindskog; Tomi Häkkinen; Kimmo Kartasalo; Martin Eklund; Pekka Ruusuvuori Journal: Virchows Arch Date: 2021-02-03 Impact factor: 4.064
Authors: Mannan Nouri; Josselin Caradec; Amy Anne Lubik; Na Li; Brett G Hollier; Mandeep Takhar; Manuel Altimirano-Dimas; Mengqian Chen; Mani Roshan-Moniri; Miriam Butler; Melanie Lehman; Jennifer Bishop; Sarah Truong; Shih-Chieh Huang; Dawn Cochrane; Michael Cox; Colin Collins; Martin Gleave; Nicholas Erho; Mohamed Alshalafa; Elai Davicioni; Colleen Nelson; Sheryl Gregory-Evans; R Jeffrey Karnes; Robert B Jenkins; Eric A Klein; Ralph Buttyan Journal: Oncotarget Date: 2017-03-21
Authors: Amar S Ahmad; Vishnu Parameshwaran; Luis Beltran; Gabrielle Fisher; Bernard V North; David Greenberg; Geraldine Soosay; Henrik Møller; Peter Scardino; Jack Cuzick; Daniel M Berney Journal: Oncotarget Date: 2018-04-17
Authors: Dawid Sigorski; Jacek Gulczyński; Aleksandra Sejda; Wojciech Rogowski; Ewa Iżycka-Świeszewska Journal: Front Oncol Date: 2021-07-01 Impact factor: 6.244